Evotec SE (EVO) Net Income Growth (1y) (2010 - 2026)
Evotec SE (EVO) Net Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | -14.93% |
| 10 | Evotec SE | 346.28 Mn | 345.76 Mn | - | -329.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -329.79% |
| Dec 31, 2025 | 42.50% |
| Sep 30, 2025 | -15.72% |
| Jun 30, 2025 | 51.86% |
| Mar 31, 2025 | -47.90% |
| Dec 31, 2024 | -131.96% |
| Sep 30, 2024 | -2.65% |
| Jun 30, 2024 | -119.73% |
| Mar 31, 2024 | -250.55% |
| Dec 31, 2023 | 49.68% |
| Sep 30, 2023 | -116.85% |
| Jun 30, 2023 | -56.07% |
| Mar 31, 2023 | 118.15% |
| Dec 31, 2022 | -172.83% |
| Sep 30, 2022 | 58.96% |
| Jun 30, 2022 | -141.25% |
| Mar 31, 2022 | -229.31% |
| Dec 31, 2021 | 3,194.59% |
| Sep 30, 2021 | 8,674.08% |
| Dec 31, 2020 | -81.90% |